Marginal Zone B-Cell Lymphomas

The Lymphomas

Volumn , Issue , 2006, Pages 406-414

  Zucca, Emanuele ^a,b   Bertoni, Francesco ^c,d   Cavalli, Franco ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882880949     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0081-9.50027-3     Document Type: Chapter

References (179)

1. NL Harris, ES Jaffe, H Stein, et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 1361-1392.
2. J Dierlamm, S Pittaluga, I Wlodarska, et al. (1996) Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87 299-307.
3. C De Wolf-Peeters, S Pittaluga, J Dierlamm, et al. (1997) Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leuk Lymphoma 26 467-478.
4. PG Isaacson, HK Muller-Hermelink, MA Piris, et al. (2001) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). ES Jaffe, NL Harris, H Stein, et al., (Eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press 157-160.
5. PG Isaacson, BN Nathwani, MA Piris, et al. (2001) Nodal marginal zone B-cell lymphoma. ES Jaffe, NL Harris, H Stein, et al., (Eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press 161.
6. PI Isaacson, MA Piris, D Catovsky, et al. (2001) Splenic marginal zone lymphoma. ES Jaffe, NL Harris, H Stein, et al., (Eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press 135-137.
7. The Non-Hodgkin's Lymphoma Classification Project. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89 3909-3918.
8. C Doglioni, AC Wotherspoon, A Moschini, et al. (1992) High incidence of primary gastric lymphoma in northeastern Italy. Lancet 339 834-835.
9. M Zaki and ML Schubert (1995) Helicobacter pylori and gastric lymphoma. Gastroenterology 108 610-612.
10. T Lopes-Carvalho and JF Kearney (2004) Development and selection of marginal zone B cells. Immunol Rev 197 192-205.
11. F Martin and JF Kearney (2002) Marginal-zone B cells. Nat Rev Immunol 2 323-335.
12. L Arcaini, M Paulli, E Boveri, et al. (2003) Marginal zone-related neoplasms of splenic and nodal origin. Haematologica 88 80-93.
13. X Sagaert and C De Wolf-Peeters (2003) Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage. Immunol Lett 90 179-186.
14. F Cavalli, PG Isaacson, RD Gascoyne, et al. (2001) MALT Lymphomas. Hematology (Am Soc Hematol Educ Program) 241-258.
15. J Yahalom, PG Isaacson, E Zucca (2004) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. PM Mauch, J Armitage, B Coiffier, et al., (Eds) Non-Hodgkin's Lymphomas Philadelphia: Lippincott Williams & Wilkins 345-360.
16. AC Feller and J Diebold (2004) Histopathology of nodal and extra-nodal non-Hodgkin's lymphomas 3rd ed. Berlin: Springer Verlag
17. B Pozzi, M Cerati and C Capella (2004) MALT lymphoma: pathology. F Bertoni, E Zucca (Eds) MALT Lymphomas Georgetown, TX: Landes Bioscience/Eurekah.com 17-45. and New York, NY: Kluwer Academic/Plenum Publishers
18. A Lavergne, JP Brouland, E Launay, et al. (1994) Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases. Cancer 74 3042-3050.
19. JK Chan (1996) Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol 13 260-296.
20. D de Jong, H Boot, P van Heerde, et al. (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 112 1466-1474.
21. AC Wotherspoon, C Doglioni, TC Diss, et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342 575-577.
22. Y Qin, A Greiner, MJ Trunk, et al. (1995) Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 86 3528-3534.
23. M Du, TC Diss, C Xu, et al. (1996) Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 10 1190-1197.
24. F Bertoni, G Cazzaniga, G Bosshard, et al. (1997) Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol 97 830-836.
25. E Zucca, F Bertoni, E Roggero, et al. (1998) Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach. Leukemia 12 247-249.
26. P Isaacson and DH Wright (1984) Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53 2515-2524.
27. E Zucca, F Bertoni, E Roggero, et al. (2000) The gastric marginal zone B-cell lymphoma of MALT type. Blood 96 410-419.
28. M Luppi and R Negrini (2004) MALT lymphoma: epidemiology ad infectious agents. F Bertoni, E Zucca (Eds) MALT Lymphomas Georgetown, TX: Landes Bioscience/Eurekah.com 17-45. and New York, NY: Kluwer Academic/Plenum Publishers
29. MQ Du and PG Isaacson (2002) Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 3 97-104.
30. J Parsonnet, S Hansen, L Rodriguez, et al. (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330 1267-1271.
31. T Hussell, PG Isaacson, JE Crabtree, et al. (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178 122-127.
32. E Zucca, F Bertoni, E Roggero, et al. (1998) Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338 804-810.
33. E Roggero, E Zucca, G Pinotti, et al. (1995) Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 122 767-769.
34. E Bayerdorffer, A Neubauer, B Rudolph, et al. (1995) Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 345 1591-1594.
35. C Garbe, H Stein, D Dienemann, et al. (1991) Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 24 584-590.
36. B Kutting, G Bonsmann, D Metze, et al. (1997) Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 36 311-314.
37. E Roggero, E Zucca, C Mainetti, et al. (2000) Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 31 263-268.
38. AJ Ferreri, M Guidoboni, M Ponzoni, et al. (2004) Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96 586-594.
39. M Lecuit, E Abachin, A Martin, et al. (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350 239-248.
40. E Zucca, E Roggero, F Bertoni, et al. (1997) Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 8 727-737.
41. IA Auer, RD Gascoyne, JM Connors, et al. (1997) t(11; 18)(q21; q21) is the most common translocation in MALT lymphomas. Ann Oncol 8 979-985.
42. G Ott, T Katzenberger, A Greiner, et al. (1997) The t(11; 18)(q21; q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57 3944-3948.
43. J Dierlamm, M Baens, M Stefanova-Ouzounova, et al. (2000) Detection of t(11; 18)(q21; q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 96 2215-2218.
44. A Rosenwald, G Ott, S Stilgenbauer, et al. (1999) Exclusive detection of the t(11; 18)(q21; q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 155 1817-1821.
45. ED Remstein, CD James and PJ Kurtin (2000) Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 156 1183-1188.
46. M Baens, B Maes, A Steyls, et al. (2000) The product of the t(11; 18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol 156 1433-1439.
47. B Maes, M Baens, P Marynen, et al. (2000) The product of the t(11; 18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type. Ann Oncol 11 521-526.
48. M Motegi, M Yonezumi, H Suzuki, et al. (2000) API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 156 807-812.
49. T Nakamura, S Nakamura, M Yonezumi, et al. (2000) Helicobacter pylori and the t(11; 18)(q21; q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 91 301-309.
50. H Liu, H Ye, A Dogan, et al. (2001) T(11; 18)(q21; q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98 1182-1187.
51. J Kalla, S Stilgenbauer, C Schaffner, et al. (2000) Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma. Leukemia 14 1967-1974.
52. H Inagaki, M Okabe, M Seto, et al. (2001) API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 158 699-706.
53. S Takada, T Yoshino, M Taniwaki, et al. (2003) Involvement of the chromosomal translocation t(11; 18) in some mucosa-associated lymphoid tissue lymphomas and diffuse large B-cell lymphomas of the ocular adnexa: evidence from multiplex reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization on using formalin-fixed, paraffin-embedded specimens. Mod Pathol 16 445-452.
54. H Ye, H Liu, A Attygalle, et al. (2003) Variable frequencies of t(11; 18)(q21; q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 102 1012-1018.
55. JA Morgan, Y Yin, AD Borowsky, et al. (1999) Breakpoints of the t(11; 18)(q21; q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59 6205-6213.
56. J Dierlamm, M Baens, I Wlodarska, et al. (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11; 18)(q21; q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93 3601-3609.
57. T Akagi, M Motegi, A Tamura, et al. (1999) A novel gene, MALT1 at 18q21, is involved in t(11; 18) (q21; q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18 5785-5794.
58. JC Reed (2000) Mechanisms of apoptosis. Am J Pathol 157 1415-1430.
59. QL Deveraux and JC Reed (1999) IAP family proteins—suppressors of apoptosis. Genes Dev 13 239-252.
60. GA Uren, K O'Rourke, L Aravind, et al. (2000) Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6 961-967.
61. H Liu, A Ruskon-Fourmestraux, A Lavergne-Slove, et al. (2001) Resistance of t(11; 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357 39-40.
62. D Sanchez-Izquierdo, G Buchonet, R Siebert, et al. (2003) MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood 101 4539-4546.
63. B Streubel, A Lamprecht, J Dierlamm, et al. (2003) T(14; 18) (q32; q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101 2335-2339.
64. J Dierlamm, C Rosenberg, M Stul, et al. (1997) Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11 747-758.
65. JR Cook, M Sherer, FE Craig, et al. (2003) T(14; 18)(q32; q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma. Hum Pathol 34 1212-1215.
66. Q Zhang, R Siebert, M Yan, et al. (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1; 14)(p22; q32). Nat Genet 22 63-68.
67. TG Willis, DM Jadayel, MQ Du, et al. (1999) Bcl10 is involved in t(1; 14)(p22; q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96 35-45.
68. R Achuthan, SM Bell, JP Leek, et al. (2000) Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma. Genes Chromosomes Cancer 29 347-349.
69. A Costanzo, C Guiet and P Vito (1999) c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB. J Biol Chem 274 20127-20132.
70. M Yan, J Lee, S Schilbach, et al. (1999) mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem 274 10287-10292.
71. SM Srinivasula, M Ahmad, JH Lin, et al. (1999) CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J Biol Chem 274 17946-17954.
72. T Koseki, N Inohara, S Chen, et al. (1999) CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to herpesvirus-2 protein E10. J Biol Chem 274 9955-9961.
73. Q Zhang, X Cui, MY Sangster, et al. (2000) Selective hyperexpansion of marginal zone (MZ) B-cells in Em-BCL10 mice. Blood 96 822a.
74. J Ruland, GS Duncan, A Elia, et al. (2001) Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104 33-42.
75. H Ye, A Dogan, L Karran, et al. (2000) BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol 157 1147-1154.
76. PC Lucas, M Yonezumi, N Inohara, et al. (2001) Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276 19012-19019.
77. LM McAllister-Lucas, N Inohara, PC Lucas, et al. (2001) Bimp1, a MAGUK family member linking PKC activation to Bcl10-mediated NF-kB induction. J Biol Chem 276 30589-30597.
78. G Pinotti, E Zucca, E Roggero, et al. (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26 527-537.
79. C Thieblemont and B Coiffier (2004) MALT lymphoma: Sites of presentations, clinical features and staging procedures. F Bertoni, E Zucca (Eds) MALT lymphomas Georgetown TX: Landes Bioscience/Eurekah.com 60-80. and New York, NY: Kluwer Academic/Plenum Publishers
80. A Dogan, M Du, A Koulis, et al. (1997) Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 151 1361-1369.
81. P Drillenburg, R van der Voort, G Koopman, et al. (1997) Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol 150 919-927.
82. P Drillenburg and ST Pals (2000) Cell adhesion receptors in lymphoma dissemination. Blood 95 1900-1910.
83. E Zucca, A Conconi, E Pedrinis, et al. (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101 2489-2495.
84. C Thieblemont, F Berger, C Dumontet, et al. (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95 802-806.
85. D de Jong, BM Aleman, BG Taal, et al. (1999) Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 10 275-280.
86. A Rohatiner, F d'Amore, B Coiffier, et al. (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5 397-400.
87. M Sackmann, A Morgner, B Rudolph, et al. (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 113 1087-1090.
88. A Ruskone-Fourmestraux, A Lavergne, PH Aegerter, et al. (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 48 297-303.
89. S Eidt, M Stolte and R Fischer (1994) Factors influencing lymph node infiltration in primary gastric malignant lymphoma of the mucosa-associated lymphoid tissue. Pathol Res Pract 190 1077-1081.
90. G Steinbach, R Ford, G Glober, et al. (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131 88-95.
91. M Stolte, E Bayerdorffer, A Morgner, et al. (2002) Helicobacter and gastric MALT lymphoma. Gut 50(Suppl 3), III19-III24.
92. A Ahmad, Y Govil and BB Frank (2003) Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 98 975-986.
93. A Conconi, F Cavalli and E Zucca (2004) Gastric MALT lymphomas: The role of antibiotics. F Bertoni, E Zucca (Eds) MALT lymphomas Georgetown TX: Landes Bioscience/Eurekah.com 81-90. and New York, NY: Kluwer Academic/Plenum Publishers
94. PG Isaacson, TC Diss, AC Wotherspoon, et al. (1999) Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology 117 750-751.
95. A Neubauer, C Thiede, A Morgner, et al. (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89 1350-1355.
96. S Nakamura, T Matsumoto, H Suekane, et al. (2001) Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 48 454-460.
97. F Bertoni, A Conconi, C Capella, et al. (2002) Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 99 2541-2544.
98. C Copie-Bergman, P Gaulard, A Lavergne-Slove, et al. (2003) Proposal for a new histological grading system for posttreatment evaluation of gastric MALT lymphoma. Gut 52 1656.
99. H Liu, H Ye, A Ruskone-Fourmestraux, et al. (2002) T(11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122 1286-1294.
100. B Alpen, A Neubauer, J Dierlamm, et al. (2000) Translocation t(11; 18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95 4014-4015.
101. C Thiede, T Wundisch, B Alpen, et al. (2001) Persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 19 1600-1609.
102. AC Wotherspoon and A Savio (2004) Molecular follow-up in gastric MALT lymhomas. F Bertoni, E Zucca (Eds) MALT lymphomas Georgetown TX: Landes Bioscience/Eurekah.com 91-98. and New York, NY: Kluwer Academic/Plenum Publishers
103. W Fischbach, M Goebeler-Kolve, P Starostik, et al. (2002) Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 360 547-548.
104. C Montalban, A Manzanal, JM Castrillo, et al. (1995) Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma. Clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination. Histopathology 27 89-91.
105. C Thieblemont, C Dumontet, F Bouafia, et al. (2003) Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976–2001. Leuk Lymphoma 44 257-262.
106. RW Tsang, MK Gospodarowicz, M Pintilie, et al. (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21 4157-4164.
107. NR Schechter, CS Portlock and J Yahalom (1998) Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 16 1916-1921.
108. M Gospodarowicz and R Tsang (2004) Radiation therapy of mucosa-associated lymphoid tissue (MALT) lymphomas. F Bertoni, E Zucca (Eds) MALT lymphomas Georgetown TX: Landes Bioscience/Eurekah.com 104-129. and New York, NY: Kluwer Academic/ Plenum Publishers
109. A Conconi, F Cavalli and E Zucca (2004) MALT lymphomas: The role of chemotherapy. F Bertoni, E Zucca (Eds) MALT lymphomas Georgetown TX: Landes Bioscience/Eurekah.com 93-103. and New York, NY: Kluwer Academic/Plenum Publishers
110. P Hammel, C Haioun, MT Chaumette, et al. (1995) Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 13 2524-2529.
111. M Levy, C Copie-Bergman, C Traulle, et al. (2002) Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 97 292-297.
112. PL Zinzani, V Stefoni, G Musuraca, et al. (2004) Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100 2190-2194.
113. G Jager, P Neumeister, R Brezinschek, et al. (2002) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a Phase II study. J Clin Oncol 20 3872-3877.
114. G Jager, G Hofler, W Linkesch, et al. (2004) Occurence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica 89 ECR01.
115. S Wohrer, J Drach, M Hejna, et al. (2003) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol 14 1758-1761.
116. A Conconi, G Martinelli, C Thieblemont, et al. (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102 2741-2745.
117. LT Chen, JT Lin, RY Shyu, et al. (2001) Prospective study of Helicobacter pylori eradication therapy in Stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 19 4245-4251.
118. C Thieblemont, Y Bastion, F Berger, et al. (1997) Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15 1624-1630.
119. PL Zinzani, M Martelli, M Magagnoli, et al. (1999) Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)gallium scan in 50 patients. Blood 94 3289-3293.
120. NR Schechter and J Yahalom (2000) Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 46 1093-1103.
121. PG Isaacson (1999) Splenic marginal zone B cell lymphoma. DY Mason, NL Harris (Eds) Human Lymphoma: Clinical Implications of the REAL Classification London: Springer-Verlag 7.1-7.6.
122. MA Piris, M Mollejo, I Chacon, et al. (2004) Splenic marginal zone B-cell lymphoma. PM Mauch, J Armitage, B Coiffier, et al., (Eds) Non-Hodgkin's Lymphomas Philadelphia: Lippincott Williams & Wilkins 275-282.
123. V Franco, AM Florena and E Iannitto (2003) Splenic marginal zone lymphoma. Blood 101 2464-2472.
124. C Thieblemont, P Felman, E Callet-Bauchu, et al. (2003) Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 4 95-103.
125. PG Isaacson, E Matutes, M Burke, et al. (1994) The histopathology of splenic lymphoma with villous lymphocytes. Blood 84 3828-3834.
126. AA Schenka, RD Gascoyne, E Duchayne, et al. (2003) Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma. Hum Pathol 34 789-791.
127. SA Kent, D Variakojis and LC Peterson (2002) Comparative study of marginal zone lymphoma involving bone marrow. Am J Clin Pathol 117 698-708.
128. J Audouin, A Le Tourneau, T Molina, et al. (2003) Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol 122 404-412.
129. FI Camacho, M Mollejo, MS Mateo, et al. (2001) Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Am J Surg Pathol 25 1268-1276.
130. G Bedu-Addo and I Bates (2002) Causes of massive tropical splenomegaly in Ghana. Lancet 360 449-454.
131. P Algara, MS Mateo, M Sanchez-Beato, et al. (2002) Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood 99 1299-1304.
132. A Tierens, J Delabie, A Malecka, et al. (2003) Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol 162 681-689.
133. D Zhu, AR Thompsett, G Bedu-Addo, et al. (1999) VH gene sequences from a novel tropical splenic lymphoma reveal a naive B cell as the cell of origin. Br J Haematol 107 114-120.
134. JP Gisbert, L Garcia-Buey, JM Pajares, et al. (2003) Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125 1723-1732.
135. CH Chan, KG Hadlock, SK Foung, et al. (2001) V(H)1–69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97 1023-1026.
136. SJ Karavattathayyil, G Kalkeri, HJ Liu, et al. (2000) Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Am J Clin Pathol 113 391-398.
137. E Zucca, E Roggero, N Maggi-Solca, et al. (2000) Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 85 147-153.
138. DJ Thalen, J Raemaekers, J Galama, et al. (1997) Absence of hepatitis C virus infection in non-Hodgkin's lymphoma. Br J Haematol 96 880-881.
139. L Arcaini, M Paulli, E Boveri, et al. (2004) Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 100 107-115.
140. O Hermine, F Lefrere, JP Bronowicki, et al. (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347 89-94.
141. I Bates, G Bedu-Addo, T Rutherford, et al. (1992) Splenic lymphoma with villous lymphocytes in tropical West Africa. Lancet 340 575-577.
142. I Bates, G Bedu-Addo, RF Jarrett, et al. (2001) B-lymphotropic viruses in a novel tropical splenic lymphoma. Br J Haematol 112 161-166.
143. R Boonstra, A Bosga-Bouwer, GW van Imhoff, et al. (2003) Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31–32. Mod Pathol 16 1210-1217.
144. F Sole, M Salido, B Espinet, et al. (2001) Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q. Haematologica 86 71-77.
145. JM Hernandez, JL Garcia, NC Gutierrez, et al. (2001) Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics. Am J Pathol 158 1843-1850.
146. AM Gruszka-Westwood, R Hamoudi, L Osborne, et al. (2003) Deletion mapping on the long arm of chromosome 7 in splenic lymphoma with villous lymphocytes. Genes Chromosomes Cancer 36 57-69.
147. CL Andersen, AMOS Gruszka-Westwood, et al. (2004) A narrow deletion of 7q is common to HCL, and SMZL, but not CLL. Eur J Haematol 72 390-402.
148. V Brito-Babapulle, AM Gruszka-Westwood, G Platt, et al. (2002) Translocation t(2; 7)(p12; q21–22) with dysregulation of the CDK6 gene mapping to 7q21–22 in a non-Hodgkin's lymphoma with leukemia. Haematologica 87 357-362.
149. S Iida, PH Rao, P Nallasivam, et al. (1996) The t(9; 14)(p13; q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 88 4110-4117.
150. H Ohno, C Ueda and T Akasaka (2000) The t(9; 14)(p13; q32) translocation in B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 36 435-445.
151. JR Cook, NI Aguilera, S Reshmi-Skarja, et al. (2004) Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9; 14). Hum Pathol 35 447-454.
152. S Gazzo, L Baseggio, L Coignet, et al. (2003) Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 88 31-38.
153. C Thieblemont, V Nasser, P Felman, et al. (2004) Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis. Blood 103 2727-2737.
154. D Catovsky and E Matutes (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Haematol 36 148-154.
155. X Troussard, F Valensi, E Duchayne, et al. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). Br J Haematol 93 731-736.
156. F Berger, P Felman, C Thieblemont, et al. (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95 1950-1956.
157. JI Chacon, M Mollejo, E Munoz, et al. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100 1648-1654.
158. C Thieblemont, P Felman, F Berger, et al. (2002) Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymphoma 3 41-47.
159. F Berger, PG Isaacson, MA Piris, et al. (2001) Lymphoplasmacytic lymphoma/Waldenstroem macroglobulinemia. ES Jaffe, NL Harris, H Stein, et al., (Eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon: IARC Press 135-137.
160. M Mollejo, J Menarguez, E Lloret, et al. (1995) Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases. Am J Surg Pathol 19 1146-1157.
161. SP Mulligan, E Matutes, C Dearden, et al. (1991) Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. Br J Haematol 78 206-209.
162. F Lefrere, O Hermine, C Belanger, et al. (2000) Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes. Leukemia 14 573-575.
163. S Bolam, J Orchard and D Oscier (1997) Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes. Br J Haematol 99 158-161.
164. F Lefrere, O Hermine, S Francois, et al. (2000) Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes. Leuk Lymphoma 40 113-117.
165. L Arcaini, E Orlandi, M Scotti, et al. (2004) Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma. Clin Lymphoma 4 250-252.
166. S Paydas, S Yavuz, U Disel, et al. (2003) Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase. Leuk Lymphoma 44 2165-2166.
167. F Berger, A Traverse-Glehen, G Salles (2004) Nodal marginal zone B-cell lymphoma. PM Mauch, J Armitage, B Coiffier, et al., (Eds) Non-Hodgkin's Lymphomas Philadelphia: Lippincott Williams & Wilkins 361-365.
168. JO Armitage, F Cavalli, E Zucca and DL Longo (2002) Nodal and splenic marginal zone B-cell lymphomas. JO Armitage, F Cavalli, E Zucca, DL Longo (Eds) Text atlas of lymphomas Revised edition London: Martin Dunitz 123-131.
169. TM Grogan (1999) Does nodal marginal zone lymphoma exist? DY Mason, NL Harris (Eds) Human Lymphoma: Clinical Implications of the REAL Classification London: Springer-Verlag 18.11-18.15.
170. R Marasca, P Vaccari, M Luppi, et al. (2001) Immunoglobulin gene mutations and frequent use of VH1–69 and VH4–34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 159 253-261.
171. A Conconi, F Bertoni, E Pedrinis, et al. (2001) Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes. Blood 98 781-786.
172. FI Camacho, P Algara, M Mollejo, et al. (2003) Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 27 762-771.
173. BN Nathwani, JR Anderson, JO Armitage, et al. (1999) Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 17 2486-2492.
174. K Sheibani, JS Burke, WG Swartz, et al. (1988) Monocytoid B-cell lymphoma. Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer 62 1531-1538.
175. B Royer, D Cazals-Hatem, J Sibilia, et al. (1997) Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90 766-775.
176. SS Shin, K Sheibani, A Fishleder, et al. (1991) Monocytoid B-cell lymphoma in patients with Sjogren's syndrome: a clinicopathologic study of 13 patients. Hum Pathol 22 422-430.
177. RI Fisher, S Dahlberg, BN Nathwani, et al. (1995) A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 85 1075-1082.
178. BN Nathwani, MR Drachenberg, AM Hernandez, et al. (1999) Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). Semin Haematol 36 128-138.
179. LP Koh, LC Lim and CH Thng (2000) Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma. Med Oncol 17 225-228.